Literature DB >> 7878933

Pilot study of mycophenolate mofetil (RS-61443) in the prevention of acute rejection following renal transplantation in Japanese patients. RS-61443 Investigation Committee--Japan.

K Takahashi1, T Ochiai, K Uchida, T Yasumura, M Ishibashi, S Suzuki, O Otsubo, K Isono, H Takagi, T Oka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7878933

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  14 in total

Review 1.  Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

Review 2.  The use of therapeutic drug monitoring to optimise immunosuppressive therapy.

Authors:  S M Tsunoda; F T Aweeka
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

3.  Polymorphisms in type I and II inosine monophosphate dehydrogenase genes and association with clinical outcome in patients on mycophenolate mofetil.

Authors:  Olivier Gensburger; Ron H N Van Schaik; Nicolas Picard; Yannick Le Meur; Annick Rousseau; Jean-Baptiste Woillard; Teun Van Gelder; Pierre Marquet
Journal:  Pharmacogenet Genomics       Date:  2010-09       Impact factor: 2.089

Review 4.  Therapeutic monitoring of mycophenolate mofetil in organ transplant recipients: is it necessary?

Authors:  Michel Mourad; Pierre Wallemacq; Josiane König; Evelyne Henry de Frahan; Djamila Chaib Eddour; Martine De Meyer; Jacques Malaise; Jean Paul Squifflet
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

5.  Pharmacokinetics of mycophenolic acid in Chinese kidney transplant patients.

Authors:  Xiao-Yang Lu; Hong-Feng Huang; Jian-Zhong Sheng-Tu; Jian Liu
Journal:  J Zhejiang Univ Sci B       Date:  2005-09       Impact factor: 3.066

Review 6.  Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation.

Authors:  B Fulton; A Markham
Journal:  Drugs       Date:  1996-02       Impact factor: 9.546

7.  Population pharmacokinetics of mycophenolic acid and dose optimization with limited sampling strategy in liver transplant children.

Authors:  Caroline Barau; Valérie Furlan; Dominique Debray; Anne-Marie Taburet; Aurélie Barrail-Tran
Journal:  Br J Clin Pharmacol       Date:  2012-09       Impact factor: 4.335

Review 8.  Mycophenolate mofetil: a pharmacoeconomic review of its use in solid organ transplantation.

Authors:  Melissa Young; Greg L Plosker
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

9.  Population pharmacokinetics and Bayesian estimation of mycophenolic acid concentrations in stable renal transplant patients.

Authors:  Chantal Le Guellec; Hélène Bourgoin; Matthias Büchler; Yann Le Meur; Yvon Lebranchu; Pierre Marquet; Gilles Paintaud
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 10.  Clinical pharmacokinetics of mycophenolate mofetil.

Authors:  R E Bullingham; A J Nicholls; B R Kamm
Journal:  Clin Pharmacokinet       Date:  1998-06       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.